Share this post on:

Product Name :
RMC-6291

Search keywords :
RMC-6291

drugId :
null

Target Vo:
KRAS G12C

Target Vo Short Name :
KRAS G12C

Moa_Name:
KRAS G12C inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Revolution Medicines Inc

Active Company_Name :
Revolution Medicines Inc

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD9 Antibody (YA524)
Ki67 Antibody (YA717)
Fatty Acid Synthase Antibody: Fatty Acid Synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 273 kDa, targeting to Fatty Acid Synthase. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related